| Hang Seng Index | 26.080 HKD | +0.600 | +2.355% | 587.03M | 15.25B | 25.470 (+2.394%) HKD as at 2025/08/12 | | |
| Hang Seng China Enterprises | 93.760 HKD | +2.520 | +2.762% | 75.40M | 6.99B | 90.963 (+3.075%) HKD as at 2025/08/11 | | |
| Hang Seng TECH Index | 5.525 HKD | +0.180 | +3.368% | 810.45M | 4.43B | 5.343 (+3.399%) HKD as at 2025/08/12 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.670 HKD | +0.365 | +6.880% | 267.10M | 1.48B | 5.323 (+6.529%) HKD as at 2025/08/12 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.506 HKD | -0.108 | -6.691% | 552.55M | 852.18M | 1.614 (-6.697%) HKD as at 2025/08/12 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.932 HKD | -0.102 | -5.015% | 247.33M | 484.20M | 2.041 (-5.331%) HKD as at 2025/08/12 | | |
| Hang Seng TECH Index | 11.850 HKD | +0.370 | +3.223% | 24.14M | 283.41M | 11.507 (+2.985%) HKD as at 2025/08/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.950 HKD | +0.275 | +4.846% | 44.27M | 259.74M | 5.649 (+5.327%) HKD as at 2025/08/12 | | |
| Hang Seng TECH Index | 5.615 HKD | +0.185 | +3.407% | 34.60M | 192.13M | 5.447 (+3.084%) HKD as at 2025/08/11 | | |
| Hang Seng China Enterprises | 10.700 HKD | +0.110 | +1.039% | 12.98M | 138.71M | 10.535 (+1.570%) HKD as at 2025/08/11 | | |
| MSCI Asia APEX 50 | 66.220 HKD | +1.240 | +1.908% | 1.11M | 73.20M | 64.867 (+2.085%) HKD as at 2025/08/11 | | |
| FTSE China A50 | 15.100 HKD | +0.090 | +0.600% | 4.81M | 72.57M | 14.852 (+1.673%) HKD as at 2025/08/11 | | |
| London Gold Fixing Price | 2,426.000 HKD | +1.000 | +0.041% | 23.27K | 56.36M | N/A | | |
| FTSE China A50 | 14.000 HKD | +0.050 | +0.358% | 3.33M | 46.76M | 13.953 (+0.340%) HKD as at 2025/08/12 | | |
| CSI 300 | 47.240 HKD | +0.400 | +0.854% | 911.18K | 43.03M | 46.768 (+1.009%) HKD as at 2025/08/12 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 11.190 HKD | +0.810 | +7.803% | 3.26M | 36.17M | 10.343 (+8.187%) HKD as at 2025/08/12 | | |
| Hang Seng Index | 26.100 HKD | +0.520 | +2.033% | 1.26M | 32.99M | 25.547 (+2.165%) HKD as at 2025/08/12 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 16.920 HKD | +0.650 | +3.995% | 1.96M | 32.87M | 16.233 (+4.233%) HKD as at 2025/08/12 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.650 HKD | -0.100 | -2.667% | 8.97M | 32.82M | 3.760 (-2.928%) HKD as at 2025/08/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 4.098 HKD | +0.084 | +2.093% | 4.91M | 20.06M | 4.036 (+1.539%) HKD as at 2025/08/12 | | |
| FTSE US Treasury 20+ Years Index | 68.520 HKD | 0.000 | 0.000% | 228.49K | 15.61M | 68.534 (-0.020%) HKD as at 2025/08/11 | | |
| Hang Seng Index | 23.860 CNY | +0.520 | +2.228% | 655.01K | 15.53M | 23.346 (+2.204%) CNY as at 2025/08/12 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.820 HKD | +0.100 | +0.679% | 1.00M | 14.80M | 14.716 (+0.709%) HKD as at 2025/08/12 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 5.035 HKD | +0.323 | +6.855% | 2.95M | 14.56M | 4.689 (+7.390%) HKD as at 2025/08/12 | | |
| Hang Seng High Dividend Yield | 30.700 HKD | +0.180 | +0.590% | 432.46K | 13.25M | 30.200 (+1.655%) HKD as at 2025/08/11 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.608 HKD | +0.158 | +4.580% | 3.70M | 13.11M | 3.424 (+5.386%) HKD as at 2025/08/12 | | |
| Short-term deposits and high quality money market investments | 9,392.550 HKD | +2.950 | +0.031% | 1.23K | 11.56M | 9,386.450 (+0.065%) HKD as at 2025/08/12 | | |
| CSI 300 | 43.280 CNY | +0.360 | +0.839% | 267.00K | 11.53M | 42.873 (+0.948%) CNY as at 2025/08/12 | | |
| CME Ether Futures | 21.900 HKD | +1.500 | +7.353% | 486.10K | 10.61M | 20.163 (+8.617%) HKD as at 2025/08/11 | | |
| CSI Hong Kong Dividend | 38.120 HKD | +0.200 | +0.527% | 267.80K | 10.21M | 37.994 (+0.331%) HKD as at 2025/08/12 | | |